Septerna SEPN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$13.8K (11 inflow days, 9 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 53.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 6.16% to 7.18% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +842,396 | 1.8% |
| PRIMECAP Management Company | Mutual Fund | 2026/Q3 | +186,879 | 2.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +145,516 | 1.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +142,515 | 4.4% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +132,615 | 2.8% |
| Morgan Stanley | Public Company | 2026/Q3 | +72,629 | 0.4% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +72,629 | 0.4% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +67,312 | 0.3% |
| Nordea Investment Management AB | Mutual Fund | 2026/Q3 | +62,183 | 0.1% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +76,979 | 0.2% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +55,148 | 0.1% |
| Loomis, Sayles & Company L.P. | Mutual Fund | 2026/Q3 | +624,752 | 1.3% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +416,746 | 2.7% |
| Algert Global LLC | Hedge Fund | 2026/Q3 | +376,452 | 0.8% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +245,252 | 3.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Jeffrey Finer | Chief Executive Officer | Intent to Sell (Form 144) | -66,000 | $48.56 | – |
| 10 Nov 2026 | R. Alan Ezekowitz | Director | Automatic Disposition | -81,820 | $51.90 | 35,600 |
| 14 Oct 2026 | Elizabeth Bhatt | President | Derivative Exercise and Sale | -4,000 | $37.61 | 174,209 |
| 30 Sep 2026 | Daniel Long | Senior Vice President of Drug Discovery | Intent to Sell (Form 144) | -10,001 | $39.13 | – |
| 30 Sep 2026 | Samira Shaikhly | Chief Human Resources Officer | Intent to Sell (Form 144) | -12,592 | $39.13 | – |
| 7 Sep 2026 | Rajiv Patni | Chief Medical Officer | Other Derivative Acquisition | +275,000 | $37.37 | 275,000 |
| 31 Aug 2026 | Daniel Long | Senior Vice President of Drug Discovery | Derivative Exercise and Sale | -3,333 | $37.83 | 96,412 |
| 11 Aug 2026 | RA Capital Management, L.P. | Private Disposition | -1,493,000 | $42.50 | 5,502,858 | |
| 11 Aug 2026 | Third Rock Ventures, LLC | Automatic Disposition | -147,200 | $51.08 | 10,280,050 | |
| 10 Aug 2026 | Elizabeth Bhatt | President | Derivative Exercise and Sale | -25,000 | $44.00 | 174,209 |
| 2 Aug 2026 | Daniel Long | Senior Vice President of Drug Discovery | Derivative Exercise and Sale | -3,334 | $34.68 | 96,412 |
| 14 Jul 2026 | Elizabeth Bhatt | President | Derivative Exercise and Sale | -4,000 | $33.99 | 174,209 |
| 30 Jun 2026 | Daniel Long | Senior Vice President of Drug Discovery | Derivative Exercise and Sale | -3,333 | $34.81 | 96,412 |
| 28 Jun 2026 | Samira Shaikhly | Chief Human Resources Officer | Derivative Exercise and Sale | -2,178 | $35.18 | 793 |
| 25 Jun 2026 | R. Alan Ezekowitz | Director | Other Derivative Acquisition | +15,000 | $37.34 | 15,000 |
| 25 Jun 2026 | RA Capital Management, L.P. | Other Derivative Acquisition | +15,000 | $37.34 | 15,000 | |
| 25 Jun 2026 | Shalini Sharp | Independent Director | Other Derivative Acquisition | +15,000 | $37.34 | 15,000 |
| 25 Jun 2026 | Jeffrey Tong | Chairperson | Other Derivative Acquisition | +15,000 | $37.34 | 15,000 |
| 25 Jun 2026 | Bernard Coulie | Independent Director | Other Derivative Acquisition | +15,000 | $37.34 | 15,000 |
| 25 Jun 2026 | Keith Gottesdiener | Independent Director | Other Derivative Acquisition | +11,260 | $37.34 | 11,260 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 3,352,395 | 7.2% | 12.0 |
| 15 Oct 2026 | 3,522,956 | 7.5% | 7.6 |
| 30 Sep 2026 | 3,096,190 | 6.6% | 8.8 |
| 15 Sep 2026 | 2,894,002 | 6.2% | 9.5 |
| 31 Aug 2026 | 2,718,332 | 5.8% | 7.7 |
| 14 Aug 2026 | 2,874,690 | 6.2% | 5.1 |
No comments yet — be the first to weigh in on SEPN.
Sign in to join the discussion.